tetano
Editor, Senior Moderator
Virology
. 2022 Sep 2;575:83-90.
doi: 10.1016/j.virol.2022.08.010. Online ahead of print.
Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease
Ajit Monteiro[SUP] 1 [/SUP], Arthur J Chang[SUP] 1 [/SUP], R Ross Welliver[SUP] 1 [/SUP], Sarah Baron[SUP] 1 [/SUP], Mark D Hicar[SUP] 2 [/SUP]
Affiliations
Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C), a post infectious complication of SARS CoV-2 infection, shares enough features with Kawasaki Disease (KD) that some have hypothesized cross-coronavirus (CoV) immunity may explain the shared pathology. Recent studies have shown that humoral cross-reactivity of the CoVs, particularly of OC43, is focused on the S2 region of the Spike protein. Due to efforts utilizing CoV S2 regions to produce a cross-CoV vaccine, we wished to assess SARS-CoV-2 S2 reactivity in children with KD and assess if cardiac involvement in KD correlated with S2 CoV antibody targeting. The presence of cross-reactivity does not distinguish KD from febrile controls and does not correlate with cardiac involvement in KD. These findings support that, in relation to cardiac vascular inflammation, vaccines targeting the S2 region appear to be a safe approach, but there is disparity in the ability of CoV species to raise cross-reactive S2 targeted antibodies.
Keywords: Coronary aneurysms; Coronavirus; Cross-immunity; Kawasaki disease; Multisystem inflammatory syndrome in children; SARS-CoV-2.
. 2022 Sep 2;575:83-90.
doi: 10.1016/j.virol.2022.08.010. Online ahead of print.
Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease
Ajit Monteiro[SUP] 1 [/SUP], Arthur J Chang[SUP] 1 [/SUP], R Ross Welliver[SUP] 1 [/SUP], Sarah Baron[SUP] 1 [/SUP], Mark D Hicar[SUP] 2 [/SUP]
Affiliations
- PMID: 36088793
- DOI: 10.1016/j.virol.2022.08.010
Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C), a post infectious complication of SARS CoV-2 infection, shares enough features with Kawasaki Disease (KD) that some have hypothesized cross-coronavirus (CoV) immunity may explain the shared pathology. Recent studies have shown that humoral cross-reactivity of the CoVs, particularly of OC43, is focused on the S2 region of the Spike protein. Due to efforts utilizing CoV S2 regions to produce a cross-CoV vaccine, we wished to assess SARS-CoV-2 S2 reactivity in children with KD and assess if cardiac involvement in KD correlated with S2 CoV antibody targeting. The presence of cross-reactivity does not distinguish KD from febrile controls and does not correlate with cardiac involvement in KD. These findings support that, in relation to cardiac vascular inflammation, vaccines targeting the S2 region appear to be a safe approach, but there is disparity in the ability of CoV species to raise cross-reactive S2 targeted antibodies.
Keywords: Coronary aneurysms; Coronavirus; Cross-immunity; Kawasaki disease; Multisystem inflammatory syndrome in children; SARS-CoV-2.